Literature DB >> 22350609

Animal models of inflammatory myopathy.

Dana P Ascherman1.   

Abstract

The idiopathic inflammatory myopathies (IIMs) represent a heterogeneous group of disorders characterized by mononuclear cell infiltration of muscle and varying degrees of muscle dysfunction. To better understand the pathogenesis of these diseases, investigators have devised a number of infectious, genetic, and antigen-induced animal models that replicate different aspects of muscle involvement. Although the underlying heterogeneity of disorders encompassed by IIM precludes development of a single unifying model, several recently developed experimental systems have provided tremendous insight regarding the contributions of both immune- and non-immune-mediated disease pathways in various subsets of IIM. In turn, by elucidating the pathogenic roles of such disparate factors as endoplasmic reticulum stress and innate immune signaling, these models have established the foundation for more novel, targeted therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350609     DOI: 10.1007/s11926-012-0245-7

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  28 in total

1.  Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.

Authors:  Sara K Custer; Manuela Neumann; Hongbo Lu; Alexander C Wright; J Paul Taylor
Journal:  Hum Mol Genet       Date:  2010-02-10       Impact factor: 6.150

2.  Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease.

Authors:  Thomas E Morrison; Robert J Fraser; Paul N Smith; Suresh Mahalingam; Mark T Heise
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

3.  Autophagy in a mouse model of distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.

Authors:  May Christine V Malicdan; Satoru Noguchi; Ichizo Nishino
Journal:  Autophagy       Date:  2007-07-12       Impact factor: 16.016

4.  Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis: implications for juvenile myositis.

Authors:  Charles Kwok-chong Li; Paul Knopp; Halima Moncrieffe; Bhanu Singh; Sonia Shah; Kanneboyina Nagaraju; Hemlata Varsani; Bin Gao; Lucy R Wedderburn
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

5.  A new murine model to define the critical pathologic and therapeutic mediators of polymyositis.

Authors:  Takahiko Sugihara; Chiyoko Sekine; Takashi Nakae; Kuniko Kohyama; Masayoshi Harigai; Yoichiro Iwakura; Yoh Matsumoto; Nobuyuki Miyasaka; Hitoshi Kohsaka
Journal:  Arthritis Rheum       Date:  2007-04

6.  Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A.

Authors:  Naoko Okiyama; Takahiko Sugihara; Yoichiro Iwakura; Hiroo Yokozeki; Nobuyuki Miyasaka; Hitoshi Kohsaka
Journal:  Arthritis Rheum       Date:  2009-08

7.  Immunization with amyloid-beta attenuates inclusion body myositis-like myopathology and motor impairment in a transgenic mouse model.

Authors:  Masashi Kitazawa; Vitaly Vasilevko; David H Cribbs; Frank M LaFerla
Journal:  J Neurosci       Date:  2009-05-13       Impact factor: 6.167

8.  Characterization of pathogenic T cells and autoantibodies in C-protein-induced autoimmune polymyositis.

Authors:  Yoh Matsumoto; Kuniko Kohyama; Il-Kwon Park; Mie Nakajima; Keiko Hiraki
Journal:  J Neuroimmunol       Date:  2007-09-27       Impact factor: 3.478

9.  IL-6-deficient mice show impaired inflammatory response in a model of myosin-induced experimental myositis.

Authors:  Flavia Scuderi; Francesca Mannella; Mariapaola Marino; Carlo Provenzano; Emanuela Bartoccioni
Journal:  J Neuroimmunol       Date:  2006-05-24       Impact factor: 3.478

10.  Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells.

Authors:  O M Zack Howard; Hui Fang Dong; De Yang; Nina Raben; Kanneboyina Nagaraju; Antony Rosen; Livia Casciola-Rosen; Michael Härtlein; Michael Kron; David Yang; Kwabena Yiadom; Sunita Dwivedi; Paul H Plotz; Joost J Oppenheim
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more
  6 in total

Review 1.  Clinical heterogeneity and outcomes of antisynthetase syndrome.

Authors:  Baptiste Hervier; Olivier Benveniste
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

2.  [New aspects on the pathogenesis of myositis].

Authors:  B Stuhlmüller; E Feist; T Häupl; G-R Burmester; N Pipitone
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

3.  Anti-Aminoacyl Transfer-RNA-Synthetases (Anti-tRNA) Autoantibodies Associated with Interstitial Lung Disease: Pulmonary Disease Progression has a Persistent Elevation of the Th17 Cytokine Profile.

Authors:  Espiridión Ramos-Martinez; Ramcés Falfán-Valencia; Gloria Pérez-Rubio; Mayra Mejia; Ivette Buendía-Roldán; Montserrat I González-Pérez; Heidegger N Mateos-Toledo; Jorge Rojas Serrano
Journal:  J Clin Med       Date:  2020-05-06       Impact factor: 4.241

4.  The correlation between cardiac and skeletal muscle pathology in animal models of idiopathic inflammatory myopathies.

Authors:  Francesco Prisco; Serenella Papparella; Orlando Paciello
Journal:  Acta Myol       Date:  2020-12-01

5.  7-Tesla magnetic resonance imaging precisely and noninvasively reflects inflammation and remodeling of the skeletal muscle in a mouse model of antisynthetase syndrome.

Authors:  Clara Sciorati; Antonio Esposito; Lara Campana; Tamara Canu; Antonella Monno; Anna Palmisano; Francesco De Cobelli; Alessandro Del Maschio; Dana P Ascheman; Angelo A Manfredi; Patrizia Rovere-Querini
Journal:  Biomed Res Int       Date:  2014-05-05       Impact factor: 3.411

6.  Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.

Authors:  Lorenzo Cavagna; Laura Nuño; Carlo Alberto Scirè; Marcello Govoni; Francisco Javier Lopez Longo; Franco Franceschini; Rossella Neri; Santos Castañeda; Walter Alberto Sifuentes Giraldo; Roberto Caporali; Florenzo Iannone; Enrico Fusaro; Giuseppe Paolazzi; Raffaele Pellerito; Andreas Schwarting; Lesley Ann Saketkoo; Norberto Ortego-Centeno; Luca Quartuccio; Elena Bartoloni; Christof Specker; Trinitario Pina Murcia; Renato La Corte; Federica Furini; Valentina Foschi; Javier Bachiller Corral; Paolo Airò; Ilaria Cavazzana; Julia Martínez-Barrio; Michelle Hinojosa; Margherita Giannini; Simone Barsotti; Julia Menke; Kostantinos Triantafyllias; Rosetta Vitetta; Alessandra Russo; Gianluigi Bajocchi; Elena Bravi; Giovanni Barausse; Roberto Bortolotti; Carlo Selmi; Simone Parisi; Carlomaurizio Montecucco; Miguel Angel González-Gay
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.